DE60136928D1 - Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme - Google Patents

Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme

Info

Publication number
DE60136928D1
DE60136928D1 DE60136928T DE60136928T DE60136928D1 DE 60136928 D1 DE60136928 D1 DE 60136928D1 DE 60136928 T DE60136928 T DE 60136928T DE 60136928 T DE60136928 T DE 60136928T DE 60136928 D1 DE60136928 D1 DE 60136928D1
Authority
DE
Germany
Prior art keywords
oil body
vaccinate
plant oil
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60136928T
Other languages
English (en)
Inventor
Anthony B Schryvers
Wendy A Hutchins
Maurice M Moloney
Joenel Alcantara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SemBioSys Genetics Inc
Original Assignee
SemBioSys Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SemBioSys Genetics Inc filed Critical SemBioSys Genetics Inc
Application granted granted Critical
Publication of DE60136928D1 publication Critical patent/DE60136928D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60136928T 2000-06-16 2001-06-15 Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme Expired - Fee Related DE60136928D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21213000P 2000-06-16 2000-06-16
PCT/CA2001/000872 WO2001095934A2 (en) 2000-06-16 2001-06-15 The use of plant oil-bodies in vaccine delivery systems

Publications (1)

Publication Number Publication Date
DE60136928D1 true DE60136928D1 (de) 2009-01-22

Family

ID=22789675

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136928T Expired - Fee Related DE60136928D1 (de) 2000-06-16 2001-06-15 Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme

Country Status (10)

Country Link
US (2) US20040081654A1 (de)
EP (1) EP1289549B1 (de)
JP (1) JP2004513879A (de)
KR (1) KR20030009538A (de)
AT (1) ATE416788T1 (de)
AU (2) AU2001267218C1 (de)
CA (1) CA2411965A1 (de)
DE (1) DE60136928D1 (de)
MX (1) MXPA02012501A (de)
WO (1) WO2001095934A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
US7601858B2 (en) 2004-08-17 2009-10-13 Gs Cleantech Corporation Method of processing ethanol byproducts and related subsystems
US9108140B2 (en) 2005-03-16 2015-08-18 Gs Cleantech Corporation Method and systems for washing ethanol production byproducts to improve oil recovery
BRPI0707942A2 (pt) * 2006-02-16 2011-05-17 Gs Ind Design Inc método e sistema para recuperar óleo de resìduos de destilação
WO2007101049A2 (en) * 2006-02-22 2007-09-07 Gs Industrial Design, Inc. Method of converting a fermentation byproduct into oxygen and biomass and related systems
CA2656022C (en) 2006-06-19 2017-10-17 The Johns Hopkins University Single-molecule pcr on microparticles in water-in-oil emulsions
AU2007291887B2 (en) 2006-09-01 2012-09-27 Csl Limited Method of eliciting or inducing an immune response
US8999353B2 (en) 2007-10-12 2015-04-07 Csl Limited Method of eliciting an immune response against pandemic influenza virus
EP2274015A2 (de) * 2008-04-11 2011-01-19 SemBioSys Genetics Inc. Gesteuerte freisetzung von wirkstoffen aus oleosomen
WO2010078556A1 (en) * 2009-01-05 2010-07-08 Epitogenesis Inc. Adjuvant compositions and methods of use
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
WO2011116220A2 (en) * 2010-03-17 2011-09-22 Arbonne International Llc Oral supplement
US10561720B2 (en) 2011-06-24 2020-02-18 EpitoGenesis, Inc. Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
JP6253210B1 (ja) * 2016-08-17 2017-12-27 一般財団法人日本生物科学研究所 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット
CN110179975B (zh) * 2019-06-15 2021-01-08 浙江大学 植物油疫苗佐剂及其制备方法和用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE218797T1 (de) * 1988-09-06 2002-06-15 Univ Washington Orale-immunisierung durch verwendung von transgenen pflanzen
US5948682A (en) * 1991-02-22 1999-09-07 Sembiosys Genetics Inc. Preparation of heterologous proteins on oil bodies
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5484719A (en) * 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US5723755A (en) * 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
AU737896B2 (en) * 1997-05-27 2001-09-06 Sembiosys Genetics Inc. Uses of oil bodies
US6761914B2 (en) * 1997-05-27 2004-07-13 Sembiosys Genetics Inc. Immunogenic formulations comprising oil bodies

Also Published As

Publication number Publication date
US20060233816A1 (en) 2006-10-19
MXPA02012501A (es) 2003-06-06
WO2001095934A3 (en) 2002-08-08
AU2001267218C1 (en) 2006-07-27
ATE416788T1 (de) 2008-12-15
EP1289549B1 (de) 2008-12-10
KR20030009538A (ko) 2003-01-29
EP1289549A2 (de) 2003-03-12
WO2001095934A2 (en) 2001-12-20
AU2001267218B2 (en) 2006-02-02
JP2004513879A (ja) 2004-05-13
AU6721801A (en) 2001-12-24
US20040081654A1 (en) 2004-04-29
CA2411965A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
DE60136928D1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
NO20015073D0 (no) Vaksiner
DK1361890T3 (da) Influenzavaccineformuleringer til intradermal indgift
DK1404363T3 (da) Adjuvanssammensætning til mucosalt og injektionsfremførte vacciner
MY126588A (en) Intranasal influenza virus vaccine
AR035586A1 (es) Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
GB2386072A (en) Novel vaccine
EP1471936A4 (de) Hiv-vakzine und anwendungsverfahren
HK1095035A1 (en) Improved inactivated fcv vaccines
DK0833903T3 (da) Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus
SE9903534D0 (sv) Vaccin
TW200509964A (en) VP1 of foot-and-mouth disease virus
AR045416A1 (es) Coadyuvante de linfocitos humanos para vacunas
MY127452A (en) Vaccines.
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
WO2002030458A8 (en) Yersinia adhesion protein as vaccine adjuvant
ITRM20010332A1 (it) Vaccini a subunita' e procedimenti per la loro produzione.
ATE305941T1 (de) Impfstoff
ATE540693T1 (de) Impfung und impfstoffe gegen hundeherpesvirus
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
MXPA01003760A (es) Vacunas atenuadas para blastomyces dermatitidis. .
RU2001103468A (ru) Способ усиления иммунного ответа при вакцинации крупного рогатого скота против бруцеллеза
RU2003137039A (ru) Способ ревакцинации взрослых людей против дифтерии и столбняка на крайнем севере

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee